Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Transcatheter Aortic Valve Replacement Market, by Material
1.4.2 North America Transcatheter Aortic Valve Replacement Market, by Implantation Procedure
1.4.3 North America Transcatheter Aortic Valve Replacement Market, by Mechanism
1.4.4 North America Transcatheter Aortic Valve Replacement Market, by End-use
1.4.5 North America Transcatheter Aortic Valve Replacement Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Transcatheter Aortic Valve Replacement Market
Chapter 4. North America Transcatheter Aortic Valve Replacement Market by Material
4.1 North America Nitinol Market by Country
4.2 North America Stainless Steel Market by Country
4.3 North America Cobalt-Chromium Market by Country
4.4 North America Others Market by Country
Chapter 5. North America Transcatheter Aortic Valve Replacement Market by Implantation Procedure
5.1 North America Transfemoral Market by Country
5.2 North America Transapical Market by Country
5.3 North America Transaortic Market by Country
Chapter 6. North America Transcatheter Aortic Valve Replacement Market by Mechanism
6.1 North America Balloon-expanding Valve Market by Country
6.2 North America Self-expanding Valve Market by Country
Chapter 7. North America Transcatheter Aortic Valve Replacement Market by End-use
7.1 North America Hospitals Market by Country
7.2 North America Ambulatory Surgical Centers Market by Country
7.3 North America Others Market by Country
Chapter 8. North America Transcatheter Aortic Valve Replacement Market by Country
8.1 US Transcatheter Aortic Valve Replacement Market
8.1.1 US Transcatheter Aortic Valve Replacement Market by Material
8.1.2 US Transcatheter Aortic Valve Replacement Market by Implantation Procedure
8.1.3 US Transcatheter Aortic Valve Replacement Market by Mechanism
8.1.4 US Transcatheter Aortic Valve Replacement Market by End-use
8.2 Canada Transcatheter Aortic Valve Replacement Market
8.2.1 Canada Transcatheter Aortic Valve Replacement Market by Material
8.2.2 Canada Transcatheter Aortic Valve Replacement Market by Implantation Procedure
8.2.3 Canada Transcatheter Aortic Valve Replacement Market by Mechanism
8.2.4 Canada Transcatheter Aortic Valve Replacement Market by End-use
8.3 Mexico Transcatheter Aortic Valve Replacement Market
8.3.1 Mexico Transcatheter Aortic Valve Replacement Market by Material
8.3.2 Mexico Transcatheter Aortic Valve Replacement Market by Implantation Procedure
8.3.3 Mexico Transcatheter Aortic Valve Replacement Market by Mechanism
8.3.4 Mexico Transcatheter Aortic Valve Replacement Market by End-use
8.4 Rest of North America Transcatheter Aortic Valve Replacement Market
8.4.1 Rest of North America Transcatheter Aortic Valve Replacement Market by Material
8.4.2 Rest of North America Transcatheter Aortic Valve Replacement Market by Implantation Procedure
8.4.3 Rest of North America Transcatheter Aortic Valve Replacement Market by Mechanism
8.4.4 Rest of North America Transcatheter Aortic Valve Replacement Market by End-use
Chapter 9. Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Product Launches and Product Expansions:
9.1.5.2 Approvals and Trials:
9.1.6 SWOT Analysis
9.2 Medtronic PLC
9.2.1 Company overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Product Launches and Product Expansions:
9.2.5.2 Approvals and Trials:
9.2.6 SWOT Analysis
9.3 Boston Scientific Corporation
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Product Launches and Product Expansions:
9.3.5.2 Acquisition and Mergers:
9.3.5.3 Approvals and Trials:
9.4 Edwards Lifesciences Corporation
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Product Launches and Product Expansions:
9.5 MicroPort Scientific Corporation
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.6 LivaNova PLC
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.7 TTK Healthcare Limited
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.8 Meril Life Sciences Private Limited
9.8.1 Company Overview
9.9 JenaValve Technology, Inc.
9.9.1 Company Overview
9.10. Bracco S.p.A.
9.10.1 Company Overview